Indaptus Therapeutics (INDP) Insider Trading & Ownership $11.19 +0.04 (+0.36%) Closing price 03:55 PM EasternExtended Trading$11.69 +0.50 (+4.47%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics (NASDAQ:INDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.80%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$191.86KNumber OfInsiders Selling(Last 3 Years)0 Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INDP Insider Buying and Selling by Quarter Indaptus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2023Glen R AndersonMajor ShareholderBuy854$65.52$55,954.08 8/10/2023Glen R AndersonMajor ShareholderBuy1,584$54.32$86,042.88 12/1/2022Boyan Vesselinov LitchevInsiderBuy17$52.36$890.12 11/22/2022Boyan Vesselinov LitchevInsiderBuy17$51.24$871.08 11/21/2022Jeffrey A MecklerCEOBuy342$53.20$18,194.40 11/18/2022Jeffrey A MecklerCEOBuy14$49.28$689.92 9/8/2022Jeffrey A MecklerCEOBuy368$78.40$28,851.20 9/7/2022Walt Addison LinscottInsiderBuy5$73.36$366.80 (Data available from 1/1/2013 forward) INDP Insider Trading Activity - Frequently Asked Questions Who is on Indaptus Therapeutics' Insider Roster? The list of insiders at Indaptus Therapeutics includes Boyan Vesselinov Litchev, Glen R Anderson, Jeffrey A Meckler, and Walt Addison Linscott. Learn more on insiders at INDP. What percentage of Indaptus Therapeutics stock is owned by insiders? 20.80% of Indaptus Therapeutics stock is owned by insiders. Learn more on INDP's insider holdings. Which Indaptus Therapeutics insiders have been buying company stock? The following insider purchased INDP shares in the last 24 months: Glen R Anderson ($141,996.96). How much insider buying is happening at Indaptus Therapeutics? Insiders have purchased a total of 2,438 INDP shares in the last 24 months for a total of $141,996.96 bought. More Insider Trading Tools from MarketBeat Related Companies Marinus Pharmaceuticals Insider Transactions Allakos Insider Transactions Rani Therapeutics Insider Transactions MiNK Therapeutics Insider Transactions Dyadic International Insider Transactions SCYNEXIS Insider Transactions FibroBiologics Insider Transactions KALA BIO Insider Transactions Tempest Therapeutics Insider Transactions Coeptis Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:INDP) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDP Stock Alerts